How This Small Biotech Is Looking To Take On Sanofi's Cash Cow - Investor's Business Daily

Apogee Therapeutics (APGE) shares crumbled Monday, reversing a steep premarket gain, despite promising results for what could become a quarterly or twice-yearly shot to control eczema. After 16 week…